MedPath
NMPA Approval

Brimonidine Tartrate and Timolol Maleate Eye Drops

国药准字H20249650

December 1, 2024

Drug Information

溴莫尼定噻吗洛尔滴眼液

眼用制剂

5ml:酒石酸溴莫尼定10.0mg和马来酸噻吗洛尔25.0mg(以C₁₃H₂₄N₄O₃S计)

化学药品

December 1, 2024

Company Information

Applicant Company

山东省枣庄市高新技术产业开发区神工路369号

Manufacturing Company

德州经济开发区晶华路

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.